Abstract:Mesenchymal stem cells (MSCs) can act as a carrier in tumor therapy, and tumor suppressor gene-modified MSCs can reach and suppress the tumor. However, in the colon cancer microenvironment, MSCs could promote tumor growth and create the environment that is conducive to the survival of cancer stem cells (CSCs). This study discovered MSCs from three sources (bone marrow, adipose, placenta) could induce the stemness and epithelial–mesenchymal transition (EMT) of HCT116 in vitro, meanwhile adipose- and placenta-derived MSCs increase the proportion of CD133+/CD44+ HCT116. Then, we explored the interaction mechanism between CD133+/CD44+ HCT116 and MSCs by the bioinformatics and in vitro assays. After CD133+/CD44+ HCT116 were co-cultured with MSCs, many cytokines in MSCs were stimulated, including interleukin-8 (IL-8). The binding of IL-8/CXCR2 activates the downstream mitogen-activated protein kinase (MAPK) signaling pathway in colon CSCs, thereby promoting the stemness and EMT. However, inhibition of IL-8/CXCR2/Erk1/2 could reverse the effect of MSCs on CSC stemness. In addition, MSCs co-cultured with CD133+/CD44+ HCT116 produce a carcinoma-associated fibroblast phenotype via intracellular FGF10–PKA–Akt–β-catenin signaling, which can be attenuated by IL-8 peptide inhibitor. To conclude, IL-8 promotes the interaction between colon CSCs and MSCs, and activates the MAPK signaling pathway in colon CSCs, which provides a theoretical basis for the application of MSCs in clinical practice. Impact statement MSCs have the property of chemotaxis and they can migrate to the tumor site by paracrine pathway in the tumor environment, and then interact with tumor cells. Although a mass of studies have been conducted about the impact of MSCs on tumors, it is still controversial whether the exogenous MSCs promote or inhibit tumor growth. In this work, we evaluated the effects of MSCs from three sources (bone marrow, adipose, placenta) on the proliferation, stemness, and metastasis of the colon cancer cells both in vitro and in vivo. Then, we proved the IL-8/CXCR2/MAPK and FGF10–PKA–Akt–β-catenin signaling pathway which mediate the interplay between MSC and CD133+/CD44+ colon cancer cell. This research aims to provide a theoretical basis for the safe application of MSCs in the clinical treatment of colon cancer.

Mesenchymal Stem Cells Show Little Tropism for the Resting and Differentiated Cancer Stem Cell-Like Glioma Cells.

Mesenchymal Stem Cells As Therapeutic Agents and in Gene Delivery for the Treatment of Glioma

Tropism of bone marrow mesenchymal stem cells for glioma

Il-8/Cxcr2 Mediates Tropism Of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Cd133(+)/Cd44(+)Colon Cancer Stem Cells

Stem Cells Tropism for Malignant Gliomas

Mesenchymal stem/stromal cells: dedicator to maintain tumor homeostasis

The uncertain role of unmodified mesenchymal stem cells in tumor progression: what master switch?

Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies

Gastric Cancer Mesenchymal Stem Cells Regulate PD-L1-CTCF Enhancing Cancer Stem Cell-Like Properties and Tumorigenesis

Glioma-associated mesenchymal stem cells

Glioblastoma-Associated Mesenchymal Stem/Stromal Cells and Cancer-Associated Fibroblasts: Partners in Crime?

Tumor-Conditioned Mesenchymal Stem Cells Display Hematopoietic Differentiation and Diminished Influx of Ca2+

Feature Article: Mesenchymal Stem Cells Maintain the Stemness of Colon Cancer Stem Cells Via Interleukin-8/Mitogen-activated Protein Kinase Signaling Pathway

The migration mechanism for glioma-directed tropism of mesenchymal stem cells:an experimental study

Mesenchymal Stem Cells in Gastric Cancer: Vicious but Hopeful

Chemotaxis of Bone Marrow-Derived Mesenchymal Stem Cells to Gastric Cancer Cells in Vivo and in Vitro

Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches

Seeing is Believing: Are Cancer Stem Cells the Loch Ness Monster of Tumor Biology?

Mesenchymal Stem Cells Inhibit Proliferation and Apoptosis of Tumor Cells: Impact on in Vivo Tumor Growth

Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells

Lung cancer-associated mesenchymal stem cells promote tumor metastasis and tumorigenesis by induction of epithelial-mesenchymal transition and stem-like reprogram